Log In
C&EN congratulates Dan Fagin on winning the 2014 Pulitzer Prize in General Nonfiction for “Toms River: A Story of Science and Salvation” (Bantam Books). C&EN’s Rudy Baum reviewed “Toms River” last May.
Copyright © 2007 American Chemical Society
January 15, 2007 Cover
Volume 85, Issue 3
Volume 85, Issue 3
STEM CELLS
Researchers are defining the chemical preferences of stem cells and figuring out what keeps them eternal and what destines them to a differentiated fate
Credit: Blake C. Porch, Howard Hughes Medical Institute
» Full Article
January 15, 2007 Issue
Volume 85, Issue 3
January 15, 2007 Issue, Vol. 85 | Iss. 3
Researchers are defining the chemical preferences of stem cells and figuring out what keeps them eternal and what destines them to a differentiated fate
(pp. 19-26)
Features
Government & Policy
Recent E. coli outbreaks heighten interest in the technology (pp. 41-43)
ACS News
Chicago hosts the annual PITTSBURGH CONFERENCE, with an expanded program and new services (pp. 56-58)
Cover Story: Taming Stem Cells
Reducing Animal Testing Using Stem Cells
Stem cells may provide a complementary alternative to animals as in vitro models of disease and for toxicological testing
Web ExclusiveGetting To The Root Of Cancer
The dark side of stem cells is initiating a revolution in cancer research
(pp. 28-29)Claims Under Fire
The future of embryonic stem cell research in the U.S. may hinge on the current review of key patents
(pp. 31-32)News of the Week
A Fast Start For Congress
Democrats quickly push controversial measures through the House
(p.12)GE Explores Plastics Sale
A sale would follow divestment of silicones business last year
(p.13)Bacterial Cooperation
Marine organisms collaborate on metabolite production
(p.15)Two Share Wolf Prize
2007 chemistry prize honors ribosome, photosynthesis advances
(p.15)Bisphenol A
Exposure to monomer causes chromosomal abnormalities in mice
(p.16)Quasicrystal Structure Solved
Structure solution draws on latest diffraction, modeling techniques
(p.16)Departments
Business
Shares of chemical firms outdid those of drug and biotech companies in the fourth quarter
(pp. 36-37)
Under new owner Danisco, Genencor drops health care strategy and focuses on enzymes
(pp. 38-39)
Industry aims to capitalize on the promise of these potent cells
Web ExclusiveConcentrates
(pp. 33-34)
(pp. 33-34)- Syngenta and Diversa pursue cellulosic biofuels
- Air Products buys Linde's Polish Unit
- BASF and Toyo deal in gas purification
- DSM aids creation of robotic 'spider'
- ISP acquires cosmetic ingredients maker
- Organon signs deal for Chinese drugs
- Gupta will receive industry medal
- PTC and Pfizer form small-molecule pact
- Boehringer, Ablynx target Alzheimer's
- VaxGen restructures after contract loss
- Seattle Genetics seals two drug pacts
- Chemical jobs fall in December
- BioVectra scores production contract
- Inex, Alnylam form technology alliance
- BUSINESS ROUNDUP
- All Concentrates
ACS News
Going global includes building partnerships worldwide and addressing violations of scientific freedom
(p.54)
Chicago hosts the annual PITTSBURGH CONFERENCE, with an expanded program and new services
(pp. 56-58)Awards(pp. 60-66)
(pp. 60-66)- ACS Award for Computers in Chemical & Pharmaceutical Research
- F. Albert Cotton Award in Synthetic Inorganic Chemistry
- Herbert C. Brown Award for Creative Work in Synthetic Methods
- ACS Award in Organometallic Chemistry
- James Bryant Conant Award in High School Chemistry Teaching
- ACS Award for Team Innovation
- Glenn T. Seaborg Award in Nuclear Chemistry
- Earle B. Barnes Award for Leadership in Chemical Research Management
- 2007 ACS National Award Winners
- All Awards
Government & Policy
Irradiation Has Benefits But May Hurt Flavor
(p.42)
Recent E. coli outbreaks heighten interest in the technology
(pp. 41-43)
Gerald Ford presided over energy, environmental milestones
(p.44)
Science & Technology
Stem cells may provide a complementary alternative to animals as in vitro models of disease and for toxicological testing
Web Exclusive
The dark side of stem cells is initiating a revolution in cancer research
(pp. 28-29)
The future of embryonic stem cell research in the U.S. may hinge on the current review of key patents
(pp. 31-32)
Researchers are defining the chemical preferences of stem cells and figuring out what keeps them eternal and what destines them to a differentiated fate
(pp. 19-26)
Action-packed presentations feature wasps, spiders, and nanotech
(pp. 46-49)
The former TV 'science guy' is a self-proclaimed nerd on a mission
(p.52)
Technology and Business news for the laboratory world
(p.53)Newscripts
Editor's Page
Most popular
Viewed
Commented
Chemistry Job Listings